BRAF mutations in thyroid cancer
The impact of BRAF mutations on the clinical outcomes of PTC remains debatable. In ATCs,
in turn, BRAF mutations identify patients eligible for targeted therapy, which is now …
in turn, BRAF mutations identify patients eligible for targeted therapy, which is now …
The relationship between thyrotropin serum concentrations and thyroid carcinoma
X Zhang, L Tian, D Teng, W Teng - Cancers, 2023 - mdpi.com
Simple Summary Thyroid-stimulating hormone (TSH) plays a role in the regulation of thyroid
hormones and is an important indicator for assessing thyroid function. Thyroid cancer (TC) is …
hormones and is an important indicator for assessing thyroid function. Thyroid cancer (TC) is …
Fasting regulates mitochondrial function through lncRNA PRKCQ-AS1-mediated IGF2BPs in papillary thyroid carcinoma
X Zhang, Y Zhong, L Liu, C Jia, H Cai, J Yang… - Cell Death & …, 2023 - nature.com
Recurring evidence suggests that fasting has extensive antitumor effects in various cancers,
including papillary thyroid carcinoma (PTC). However, the underlying mechanism of this …
including papillary thyroid carcinoma (PTC). However, the underlying mechanism of this …
Dual targeting of MAPK and PI3K pathways unlocks redifferentiation of Braf-mutated thyroid cancer organoids
H Lasolle, A Schiavo, A Tourneur, P Gillotay… - Oncogene, 2024 - nature.com
Thyroid cancer is the most common endocrine malignancy and several genetic events have
been described to promote the development of thyroid carcinogenesis. Besides the effects of …
been described to promote the development of thyroid carcinogenesis. Besides the effects of …
Could oxidative stress play a role in the development and clinical management of differentiated thyroid cancer?
M Kościuszko, A Buczyńska, AJ Krętowski… - Cancers, 2023 - mdpi.com
Simple Summary Increased oxidative stress (OS) has been implicated as a relevant risk
factor for cancer development and progression. The incidence of differentiated thyroid …
factor for cancer development and progression. The incidence of differentiated thyroid …
Management of radioiodine refractory differentiated thyroid cancer: the Latin American perspective
F Pitoia, RS Scheffel, I Califano, A Gauna… - Reviews in Endocrine …, 2024 - Springer
Radioiodine (RAI) refractory differentiated thyroid cancer is an uncommon and challenging
situation that requires a multidisciplinary approach to therapeutic strategies. The definition of …
situation that requires a multidisciplinary approach to therapeutic strategies. The definition of …
The Presence of Typical “BRAFV600E-Like” Atypia in Papillary Thyroid Carcinoma is Highly Specific for the Presence of the BRAFV600E Mutation
J Turchini, L Sioson, A Clarkson, A Sheen… - Endocrine …, 2023 - Springer
Papillary thyroid carcinomas (PTCs) are driven by a variety of molecular abnormalities
including BRAF, RAS, ALK, RET, and NTRK alterations. PTCs driven by the BRAFV600E …
including BRAF, RAS, ALK, RET, and NTRK alterations. PTCs driven by the BRAFV600E …
Treatment strategies for low-risk papillary thyroid carcinoma: a position statement from the Thyroid Department of the Brazilian Society of Endocrinology and …
Increasingly sensitive diagnostic methods, better understanding of molecular
pathophysiology, and well-conducted prospective studies have changed the current …
pathophysiology, and well-conducted prospective studies have changed the current …
Risk stratification of papillary thyroid cancers using multidimensional machine learning
Y Li, F Wu, W Ge, Y Zhang, Y Hu, L Zhao… - … Journal of Surgery, 2024 - journals.lww.com
Background: Papillary thyroid cancer (PTC) is one of the most common endocrine
malignancies with different risk levels. However, preoperative risk assessment of PTC is still …
malignancies with different risk levels. However, preoperative risk assessment of PTC is still …
[Retracted] LncRNA‐PAX8‐AS1 Silencing Decreases Cell Viability, Enhances Apoptosis, and Suppresses Doxorubicin Resistance in Myeloid Leukemia via the miR …
X Song, Y Chen, Y Peng, X Wang… - Evidence‐Based …, 2022 - Wiley Online Library
Objective. Considering the role of lncRNAs reported as regulators in acute myeloid leukemia
(AML) progression, the current research aims to investigate the role of PAX8‐AS1 in chemo …
(AML) progression, the current research aims to investigate the role of PAX8‐AS1 in chemo …